Cancer Vaccines: The Interleukin 2 Dosage Effect.

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.92.10.4711
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Personal Neoantigen Cancer Vaccines

OncoImmunology
OncologyAllergyImmunology
2014English

Erratum: Rekindling Cancer Vaccines

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2016English

DNA Vaccines for Prostate Cancer

Pharmacology and Therapeutics
Pharmacology
2017English

Listeria Vaccines for Pancreatic Cancer

2013English

Prospects for the Future of Prostate Cancer Vaccines

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2015English

Modifying the Cancer-Immune Set Point Using Vaccinia Virus Expressing Re-Designed Interleukin-2

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Development of a Novel Class of Interleukin-2 Immunotherapies for Metastatic Cancer

Swiss Medical Weekly
Medicine
2019English

RNA-Based Vaccines in Cancer Immunotherapy

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy